156100 — L&K Biomed Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩174bn
- KR₩173bn
- KR₩30bn
- 28
- 14
- 51
- 16
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26,575 | 19,356 | 15,373 | 19,767 | 29,905 |
Cost of Revenue | |||||
Gross Profit | 12,697 | 13,496 | 7,461 | 14,889 | 25,765 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 42,604 | 26,044 | 31,395 | 33,377 | 42,583 |
Operating Profit | -16,029 | -6,688 | -16,022 | -13,610 | -12,678 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13,839 | -9,239 | -8,897 | -16,299 | -6,468 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11,573 | -10,672 | -13,646 | -16,233 | -5,239 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -10,766 | -10,715 | -9,669 | -13,625 | -1,867 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10,766 | -10,715 | -9,669 | -13,625 | -1,867 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -503 | -640 | -633 | -892 | 474 |
Dividends per Share |